References
- Bliss C. I. Statistics in Biology. McGraw-Hill, New York 1967
- Cairns J. A., Missirlis E., Fallen E. L. Myocardial infarction size from serial CPK: variability of CPK serum entry ratio with size and model of infarction. Circulation 1978; 58: 1143
- Clark G. L., Robinson A. K., Gnepp D., Roberts R., Sobel B. E. Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circulation Res 1978; 43: 162
- Cobb F. R., Irvin R. G., Hagerty R. C., Roe C. C. Effect of extension of infarction on serial CK activitiy. Circulation 1979; 60: 145
- Committee on Enzymes, Scandinavian Society for Clinical Chemistry. Recommended methods for the determination of four enzymes in blood. Scand. J. clin. Lab. Invest 1974; 33: 291
- Hørder M., Magid E., Pitkänen E., Härkönen M., Strømme J. H., Theodorsen L., Gerhardt W., Waldenström J. Recommended method for the determination of creatine kinase in blood modified by the inclusion of EDTA. Scand. J. clin. Lab. Invest 1972; 39: 153
- Malmberg P. Aspartate aminotransferase activity in dog heart lymph after myocardial infarction. Scand. J. clin. Lab. Invest 1972; 30: 153
- Mathey D., Bleifeld W., Buss H., Hanrath P. Creatine kinase release in acute myocardial infarction: correlation with clinical electrocardiographic, and pathological findings. Brit. Heart J 1975; 37: 1161
- Norris R. M., Whitlock R. M.L., Barratt-Boyes C., Small C. W. Clinical measurement of myocardial infarct size. Circulation 1975; 51: 614
- Peter T., Norris R. M., Clarke E. D., Heng M. K., Singh B. N., Williams B., Howell D. R., Ambler P. K. Reduction of enzvme levels bv propranolol. After acute myocardial infarction. Circulation 1978; 57: 1091
- Hyltoft Petersen P., Dreyer T. Electroimmuno-assay of α1--antitrypsin with high precision. Scand. J. clin. Lab. Invest 1976; 36: 103
- Roe C. R. Validity of estimating myocardial infarct size from serial measurements of enzyme activity in the serum. Clin. Chem 1977; 23: 1807
- Roe C. R., Starmer C. F. A sensitivity analysis of enzymatic estimation of infacrt size. Circulation 1975; 52: 1
- Smith S. J., Bos G., Hagemeyer F., Hermens W., Th., Witteveen S. A.G.J. Influences of changes in plasma volume on quantitation of infarct size in man by means of plasma enzyme levels. J. molec. Med 1976; 1: 199
- Sobel B. E., Markham J., Karlsberg P. R., Roberts R. The nature of disappearance of creatine kinase from the circulation and its influence on enzymatic estimation of infarct size. Circulation Res 1977; 41: 836
- Sobel B. E., Roberts R., Larson K. B. Considera-tations in the use of biochemical markers of ischemic injury. Circulation Res 1976; 138: 99
- Sobel B. E., Roberts R., Larson K. B. Estimation of infarct size from serum MB creatine phospho-kinase activity: Applications and limitations. Am. J. Cardiol 1976; 31: 474
- Thygesen K., Hørder M., Lyager Nielsen B., Hyltoft Petersen P. The variability of ST segment in early phase of acute myocardial infarction. Acta med. scand. 1979; 623: 61, Suppl
- Witteveen S. A.G.J., Hemker H. C., Hollaar L., Hermens W., Th. Quantitation of infarct size in man by means of plasma enzyme levels. Brit. Heart J. 1975; 31: 795
- Working group on the establishment of ischemic heart disease registers. Report of the fifth working group. WHO, Euro, Copenhagen 1971; 8201(5)
- Yasmineh W. G., Pyle R. B., Cohn J. N., Nicoloff D. M., Hansson N. Q., Steele B. W. Serial serum creatine phosphokinase MB isoenzyme activity after myocardial infarction (Studies in the Baboon and Man). Circulation 1977; 55: 733